Pulse Biosciences, Inc.

About Pulse Biosciences, Inc.

Pulse Biosciences is a company pioneering the research, design, and production of patented nPulse™ technology for high-impact healthcare applications. Their mission focuses on applying proprietary Nanosecond Pulse Field Ablation (nsPFA) technology for soft tissue ablation, including treatments for benign thyroid tumors and atrial fibrillation, with the potential to benefit patients across various therapy areas.

Products & Services

nPulse™ Vybrance™ Percutaneous Ablation System:A system designed for nonthermal, minimally invasive treatment of benign thyroid nodules using nsPFA technology.

nsPFA™ Cardiac Surgery Ablation System:A system for surgical cardiac ablation, aimed at producing continuous linear transmural ablations with safety and performance benefits over thermal ablation technologies.

nsPFA™ 360 Catheter Endocardial Ablation System:A catheter system for endocardial ablation, focused on rapid pulmonary vein isolation for atrial fibrillation treatment using nsPFA technology.

Specialties

Nanosecond Pulse Field Ablation (nsPFA) technology Soft tissue ablation Cardiac ablation for atrial fibrillation Treatment of benign thyroid nodules

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Rights Offering T: - FT: Rights Offering	A: 60000000 MR: - FA: $60 million FAN: 60000000	D: 2024-07-03 FD: 2024-07-03	1 investors
2	RT: Rights Offering T: - FT: Rights Offering	A: 60000000 MR: - FA: $60 million FAN: 60000000	D: 2024-06-28 FD: 2024-06-28	1 investors
3	RT: Rights Offering T: - FT: Rights Offering	A: 60000000 MR: - FA: up to $60,000,000 FAN: 60000000	D: 2024-06-04 FD: 2024-06-04	-
4	RT: Rights Offering T: - FT: Rights Offering	A: 60000000 MR: - FA: up to $60,000,000 FAN: 60000000	D: 2024-05-20 FD: 2024-05-20	-
5	RT: Rights Offering T: - FT: Rights Offering	A: 60000000 MR: - FA: up to $60,000,000 FAN: 60000000	D: 2024-05-02 FD: 2024-05-02	-
6	RT: Rights Offering T: - FT: Rights Offering	A: 60000000 MR: - FA: up to $60 million FAN: 60000000	D: 2024-03-28 FD: 2024-03-28	1 investors
7	RT: Private Placement T: - FT: Private Placement	A: 65000000 MR: - FA: 65 million FAN: 65000000	D: 2023-08-24 FD: 2023-08-24	1 investors
8	RT: Private Placement T: - FT: Private Placement	A: 65000000 MR: - FA: 65 million FAN: 65000000	D: 2023-05-01 FD: 2023-05-01	1 investors

Rights Offering Latest

2024-07-03

$60.0M

1 investor (Pro only)

Rights Offering 2024-06-28

$60.0M

Rights Offering 2024-06-04

$60.0M

View 7 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jan Petru

Cardiac Electrophysiologist

M

Moritoshi Funasako

Cardiac Electrophysiologist

V

Vivek Reddy

Director of Cardiac Arrhythmia Services

P

Petr Neuzil

Professor

G

Gregory Michaud

Cardiac Electrophysiologist

D

David Kenigsberg

Chief Medical Officer of Electrophysiology

View 10 more team members with Pro

Unlock Full Team Directory

Recent News